| Literature DB >> 29137643 |
Feng Peng1,2,3, Xinyue Wang1,2,3, Yang Sun1,2,3, Guibin Dong1,2,3, Yankun Yang1,2,3, Xiuxia Liu4,5,6, Zhonghu Bai7,8,9.
Abstract
BACKGROUND: Corynebacterium glutamicum (C. glutamicum) has traditionally been used as a microbial cell factory for the industrial production of many amino acids and other industrially important commodities. C. glutamicum has recently been established as a host for recombinant protein expression; however, some intrinsic disadvantages could be improved by genetic modification. Gene editing techniques, such as deletion, insertion, or replacement, are important tools for modifying chromosomes.Entities:
Keywords: CRISPR/Cas9; Corynebacterium glutamicum; Genome editing; Protein expression
Mesh:
Substances:
Year: 2017 PMID: 29137643 PMCID: PMC5686833 DOI: 10.1186/s12934-017-0814-6
Source DB: PubMed Journal: Microb Cell Fact ISSN: 1475-2859 Impact factor: 5.328
Fig. 1Design of the CRISPR/CAS9 system for gene deletion in C. glutamicum. a Strategy for construction of pFSC. Cas9 is controlled by the IPTG-inducible Ptac promoter, the SD sequence is designed to enhance the expression of Cas9; b strategy for construction of pFST. The sgRNA cassette is under the control of the IPTG-inducible Ptrc promoter, the 20 nt target sequence is shown in gold, the backbone is a temperature sensitive repA replicon, the HDarm is ligated into pFST at the BglII site; c strategy for construction of the sgRNA. The red N20 is the 20 nt target sequence, and the underlined sequences are the sgRNA scaffold. The EcoRI and XbaI sites are used to assemble the sgRNA into pFST
The PAM site and the sgRNA sequence used in this study
| Gene | PAM sequence | PAM site and gene length | Target strand | GC (%) |
|---|---|---|---|---|
|
| GGAGGATAGGTTTGCGAAGT | 83/381 | NT | 50 |
|
| GGCACCT TCACCTCAGGATT | 214/576 | T | 55 |
|
| GGCTGAAATCTCCGACGGCT | 194/1281 | NT | 60 |
| Ncgl0911 | GGTAACTGGGCTGGCCAAAA | 62/1260 | NT | 55 |
|
| GGTGGCGGTAGCGGTTGCGG | 62/576 | NT | 75 |
|
| GGATGCTGGTGCCATGGTGG | 77/576 | NT | 65 |
|
| GGAGGAAAGGCCTGCGTAGT | 108/576 | NT | 60 |
|
| GGCGGCTGGTGCGACGGCGG | 173/576 | NT | 85 |
|
| GGCCAGGAAATCGCAGGAAT | 445/576 | T | 55 |
|
| GGCAGCCAAGGATTCTCCAC | 467/576 | T | 60 |
The PAM sites are shown in underline. NT and T mean sgRNAs targeting to the template (T) or nontemplate (NT) respectively
Results of the porB deletion in C. glutamicum ATCC 13032 and C. glutamicum CGMCC1.15647
| No | Host cell | Plasmid | Element | Results (D/W/T) | Efficiency (%) |
|---|---|---|---|---|---|
| 1 | ATCC 13032 | pFSC | cas9 | 0/5/5 | 0 |
| 2 | ATCC 13032 | pFST-porBsgRNA | sgRNA | 0/5/5 | 0 |
| 3 | ATCC 13032 | pFST-porBT | Hdarm | 0/5/5 | 0 |
| 4 | ATCC 13032 | pFSC, pFST-porBT | Cas9 + Hdarm | 0/5/5 | 0 |
| 5 | ATCC 13032 | pFSC, pFST-porBsgRNA | Cas9 + sgRNA | 0/0/0 | 0 |
| 6 | ATCC 13032 | pFST-porB | sgRNA + Hdarm | 0/6/6 | 0 |
| 7 | ATCC 13032 | pFSC, pFST-porB | Cas9 + sgRNA + Hdarm (1000 bp) | 18/0/18 | 100 |
| 8 | CGMCC 1.15647 | pFSC, pFST-porB15647 | Cas9 + sgRNA + Hdarm (1000 bp) | 16/0/16 | 100 |
| 9 | ATCC 13032 | pFSC, pFST-porB600 | Cas9 + sgRNA + Hdarm (600 bp) | 10/2/12 | 83.3 |
| 10 | ATCC 13032 | pFSC, pFST-porB300 | Cas9 + sgRNA + Hdarm (300 bp) | 10/2/12 | 83.3 |
| 11 | ATCC 13032 | pFSC, pFST-porB100 | Cas9 + sgRNA + Hdarm (100 bp) | 2/10/12 | 16.7 |
D, number of colonies that harbored gene-deleted cells; W, number of colonies that harbored wild type cells; T, total number of colonies used for PCR screening; Efficiency, probability of deletion events occurring, calculated as D/T * 100%; ATCC 13032, C. glutamicum ATCC 13032; CGMCC 1.15647, C. glutamicum CGMCC1.15647
Fig. 2CRISPR/Cas9-mediated genome editing in C. glutamicum ATCC 13032 and C. glutamicum CGMCC1.15647. a Schematic depicting editing procedures. The left and right arms are regions from the targeted gene and are amplified by PCR from C. glutamicum genomic DNA. LF and LR primers are used to amplify the left arm, and RF and RR primers are used to amplify the right arm. For Gibson assembly, the 5′ end of LF contains a 20 bp overhang region of the 5′ end of the BglII site from the pFST plasmid. The 5′ end of LR contains a 10 bp overhang region of the 5′ end of the right arm. The 5′ end of RF contains a 10 bp overhang region of the 3′ end of the left arm. The 5′ end of RR contains a 20 bp overhang region of the 3′ end of the BglII site from the pFST plasmid. CF and CR are primers for PCR validation of editing efficiency. The SEQ primer is used for sequencing. b The CRISPR/Cas9 system mediated disruption of the porB gene in C. glutamicum ATCC 13032. The editing efficiency was 18/18. The lane ‘ck’ is the PCR product from the wild-type strain. These results were confirmed by sequencing. c The CRISPR/Cas9 system mediated disruption of the proB gene in C. glutamicum CGMCC1.15647. The editing efficiency was 16/16
Fig. 3Evaluation of editing efficiency with different arm sizes. a Design of HDarms of various sizes (600, 300, 100 bp). Both sides of the HDarm contain a 20 bp overhang region of the BglII site from the pFST plasmid. b Disruption of the porB gene mediated by the CRISPR/Cas9 system in C. glutamicum ATCC 13032 with a 600 bp HDarm. The editing efficiency was 10/12, the lane ‘ck’ is the PCR product from the wild-type strain. c Disruption of the porB gene mediated by the CRISPR/Cas9 system in C. glutamicum ATCC 13032 with a 300 bp HDarm. The editing efficiency was 10/12. d Disruption of the porB gene mediated by the CRISPR/Cas9 system in C. glutamicum ATCC 13032 with a 100 bp HDarm. The editing efficiency was 2/12
Fig. 4Genome editing mediated by CRISPR/Cas9 in C. glutamicum ATCC 13032. a Schematic depicting editing procedures, the PAM site and gene length. b Disruption of the mepA gene mediated by the CRISPR/Cas9 system in C. glutamicum ATCC 13032. The editing efficiency was 2/15. The lane ‘ck’ is the PCR product from the wild-type strain. c Disruption of the clpX gene mediated by the CRISPR/Cas9 system in C. glutamicum ATCC 13032. The editing efficiency was 5/16. d Disruption of the Ncgl0911 gene mediated by the CRISPR/Cas9 system in C. glutamicum ATCC 13032. The editing efficiency was 4/15
Fig. 5Point mutation and gene insertion mediated by the CRISPR/Cas9 system in C. glutamicum ATCC 13032. a Schematic depicting the procedure for generating point mutations. The 5′ end of LR contains a 10 bp overhang region of the 5′ end of the right arm. The 5′ end of RF contains a 10 bp overhang region of the 3′ end of the left arm. The point mutation site was designed in the primers FR and RF. CF and CR are primers for PCR validation of editing efficiency. The SEQ primer is used for sequencing. b Schematic depicting the procedure for gene insertion. The 5′ end of the LR contains a 10 bp overhang region of the 5′ end of GFP. The 5′ end of GFPF contains a 10 bp overhang region of the 3′ end of the left arm. The 5′ end of GFPR contains a 10 bp overhang region of the 5′ end of the right arm. The 5′ end of RF contains a 10 bp overhang region of the 3′ end of the GFP arm. c The point mutation mediated by CRISPR/Cas9 in C. glutamicum ATCC 13032. The mutation efficiency was 6/6 and was confirmed by sequencing. d Gene insertion mediated by CRISPR/Cas9 in C. glutamicum ATCC 13032. The porB gene was replaced by the gfp gene. The efficiency for gfp insertion was 8/12, confirmed by PCR and sequencing
Results of the mepA deletion in C. glutamicum ATCC 13032
| Plasmid | Element | Results (D/W/T) | Efficiency (%) |
|---|---|---|---|
| pFSC, pFST-mepA1 | Cas9 + sgRNA1 + Hdarm (300 bp) | 3/9/12 | 25 |
| pFSC, pFST-mepA2 | Cas9 + sgRNA2 + Hdarm (300 bp) | 0/12/12 | 0 |
| pFSC, pFST-mepA3 | Cas9 + sgRNA3 + Hdarm (300 bp) | 10/2/12 | 83.3 |
| pFSC, pFST-mepA4 | Cas9 + sgRNA4 + Hdarm (300 bp) | 4/8/12 | 33.3 |
| pFSC, pFST-mepA5 | Cas9 + sgRNA5 + Hdarm (300 bp) | 12/0/12 | 100 |
| pFSC, pFST-mepA6 | Cas9 + sgRNA6 + Hdarm (300 bp) | 6/6/12 | 50 |
D, number of colonies that harbored gene-deleted cells; W, number of colonies that harbored wild type cells; T, total number of colonies used for PCR screening; Efficiency, probability of deletion events occurring, calculated as D/T * 100%
Fig. 6Growth phenotypes of the porB, mepA, clpX and Ncgl0911-deleted strains. WT, wild-type strain; MporB, porB-deleted mutant; MmepA, mepA-deleted mutant; M0911, Ncgl0911-deleted mutant; MclpX, clpX-deleted mutant; the clpX mutant showed impaired growth compared with the wild-type strain while the other mutants showed the same growth rate as the wild-type. Date are representative of triplicate cultures
Fig. 7GFP expression in the porB, mepA, clpX and Ncgl0911-deleted strains. CK is a negative control of the wild-type strain containing pXMJ19 without the gfp gene. WT-GFP is a positive control of the wild-type strain containing pXMJ19-EGFP; MmepA-GFP is the mepA-deleted mutant with plasmid pXMJ19-EGFP; MmepA-mepA-GFP is the mepA-deleted mutant complemented by mepA gene and containing pXMJ19-EGFP; MporB-GFP is the porB-deleted mutant with plasmid pXMJ19-EGFP; MporB-porB-GFP is the porB-deleted mutant complemented by porB gene and containing pXMJ19-EGFP. a Fluorescence intensities normalized against culture OD600 were used to indicate the expression of GFP. b The expression of GFP was determined by fluorescence microscopy with an exposure time of 1 s. The mepA and porB mutants showed GFP expression enhanced by 55.2 and 62.4%, respectively, relative to the wild type